Suppression of angiogenesis causes a significant delay of repair process in rat thromboembolic cerebral infarction

Journal of Tokyo Medical University

Volumn 60, Issue 6, 2002, Pages 489-500

  Feng, Yi ^a   Kudo, Motoshige ^a   Shimoke, Koji ^b   Ikeuchi, Toshihiko ^b   Ebihara, Yoshiro ^a   Takasaki, Masaru ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KANSAI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Apoptosis; Cyclophosphamide; Experimental cerebral infarction; Macrophage; Rats

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; RAT; REGENERATION; THROMBOEMBOLISM; TISSUE REPAIR; WESTERN BLOTTING;

EID: 0036880395     PISSN: 00408905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tufro-McReddie A, Norwood VF, Aylor KW, Botkin SJ, Carey RM, Gomez RA: Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev Boil 183: 139-149, 1997
2. Szpak GM, Lechowicz W, Lewandowska E, Bertrand E, Teresa WB, Dymecki J: Border zone neovascularization in cerebral ischemic infarct. Folia Neuropathol 37: 264-268, 1999
3. Krupinski J, Kumar P, Kumar S, Path FRC, Kaluza J: Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27: 852-857, 1996
4. Marchal G, Serrari C, Rioux P, Petit-Taboue MC, Viader F, de-la-Sayette V, Le-Doze F, Lochon P, Derlon JM, Orgogozo JM: PET imaging of cerebral perfusion and oxygen comsumption in acute ischaemic stroke: Relation to outcome. Lancet 341: 925-927, 1993
5. Krupinski J, Kaluza J, Kumar P, Kumar S, Path FRC, Wang JM: Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798, 1994
6. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J: Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 173: 114-128, 2002
7. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, Mackenzie ET, Petit E: A potential role of erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651, 1999
8. Mitsuyama T, Kawamata T, Yamane F, Awaya A, Hori T: Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal ischemia in rats. J Neurosurg 96: 1072-1076, 2002
9. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J: Serial measurement of vascular endothelial growth factor and transforming growth factor-beta 1 in serum of patients with acute ischemia stroke. Stroke 31: 1863-1870, 2000
10. Mcpherson JM: The utility of collagen-based vehicles in delivery of growth factors for hard and soft tissue wound repair. Clin Mater 9: 225-234, 1992
11. Dhodda VK, Sailor K, Dempsey RJ, Vemuganti RLR: Novel mediators of ischemic preconditioning induced neuroprotection. J Neurochem 81: 108-111, 2002
12. Zagzag D, Capo V: Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases". Histol Histopathol 17: 301-321, 2002
13. Hayashi T, Abe K, Suzuki H, Itoyama Y: Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28: 2039-2044, 1997
14. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W: Hypoxia-induced Vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156: 965-976, 2000
15. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C: Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 58: 654-666, 1999
16. Isenmann S, Stoll G, Schroeter M, Krajewski S, Reed JC, Bahr M: Different regulation of bax, bcl-2, and bcl-x proteins in focal cortical ischemia in the rat. Brain pathol 8: 49-63, 1998
17. Kitagawa H, Hayashi T, Mitsumoto Y, Koga N, Itoyama Y, Abe K: Reduction of ischemic brain injury by topical application of glial cell-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 29: 1417-1422, 1998
18. Shimoke K, Kudo M: 1-Metyl-4-phenyl-1,2,3,6-tetrahydropyridine has a transient proliferative effect on PC12h cells and never growth factor additively promotes this effect: possible involvement of distinct mechanisms of activation of MAP kinase family proteins. Dev Brain Res 133: 105-114, 2002
19. Seigel GM, chiu L, Paxhia A: Inhibition of neuronretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis 6: 157-163, 2000
20. Watanabe I, Toyoda M, Okuda J, Tenjo T, Tanaka K, Yamamoto T, Kawasaki H, Sugiyama T, Kawarada Y, Tanigawa N: Detection of apoptotic cells in human colorectal cancer by two different in situ methods: antibody against single-stranded DNA and terminal deooxynucleotidyl transferase-mediated dUPT-biotin nick end-labeling(TUNEL)methods. Jpn J Cancer Res 90: 188-193, 1999
21. Maeda M, Sugiyama T, Akai F, Jikihara I, Hayashi Y, Takagi H: Single stranded DNA as an immunocytochemical marker for apoptotic change of ischemia in the gerbil hippocampus. Neurosci Lett 240: 69-72, 1998
22. Placidi L, Scott EC, Eckoff D, Bynon S, Sommadossi JP: Metabolic drug interactions between angiogenic inhibitor, TNP-470 and anticancer agents in primary cultured hepatocytes and microsomes. Drug Metab Dispos 27: 623-626, 1999
23. Castanon M, Mayol J, Munoz ME, Carrasco R, Morales L: Interferon treatment of giant hemangioma. Cir Pediatr 12: 80-82, 1999
24. Kachel DL, Martin WJ: Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther 268: 42-46, 1994
25. Browder T, Butterfield CE, Kraling BM, Shi B, O' Reilly MS, Folkman J: Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60: 1878-1886, 2000
26. Kudo M, Aoyama A, Ichimori S, Fukunaga N: An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke 13: 505-508, 1982
27. Murren JR, Anderson S, Fedele J, Pizzorno G, Belliveau D, Zelterman D, Burtness BA, Tocino I, Flynn SD, Beidler D, Cheng YC: Dose-escalation and pharmacodynamic study of tepotecan in combination with cyclophosphamide in patients with refractory cancer. J Clin Oncol 15: 148-157, 1997
28. Hama Y: Vascular architecture in experimental cerebral infarction: effects of cyclophosphamide administration. J Med Soc Toho (Japan) 29: 594-605, 1983
29. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 798-801, 1992
30. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJS, Aglietta M, Arese P, Mantovani A: Granulocyte- and granulocytemacrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337: 471-473, 1989
31. Ata AK, Funa K, Olsson Y: Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesion. Acta Neuro 93: 326-333, 1997
32. Kudo M: An ultrastructural and enzyme histochemical study on origin of macrophages and histogenesis of gliosis in experimental cerebral infarction. J Med Soc Toho (Japan) 22: 152-173, 1975
33. Kang NP, Kudo M: The origin of brain macrophages: An experimental study. J Med Soc Toho (Japan) 30: 763-787, 1984
34. Hickey WF: Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1: 97-105, 1991
35. Oh KY, Kudo M: Transmission and scanning electron microscopic observation of macrophages in experimental cerebral infarcts in rats. J Med Soc Toho (Japan) 35: 246-256, 1988
36. Hayashi T, Abe K, Itoyama Y: Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18: 887-895, 1998
37. Asai A, Qiu Jh, Narita Y, Chi S, Saito N, Shinoura N, Hamada H, Kuchino Y, Kirino T: High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem 274: 34450-34458, 1999
38. Munshi NC, Barlogie B, Desikan KR, Wilson C: Novel approaches in myeloma therapy. Semin Oncol 26: 28-34, 1999
39. Lee K, Erturk E, Mayer R, Cockett AT: Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer Res 47: 5021-5024, 1987